| Document Date: 2014-05-27 14:10:03
Open Document File Size: 646,85 KBShare Result on Facebook
City Reference / / Company Boehringer Ingelheim Pharmaceuticals Inc. / Ames / / Event FDA Phase / / Facility Laboratory Tests *Sections / Poison Control Center / Laboratory Tests Changes / / IndustryTerm treatment for diabetes / food / / MedicalCondition insulin resistance / fetal resorptions / lymphoma / tumors / arthralgia / headache / nasopharyngitis / hypertriglyceridemia / reported hypoglycemia / Carcinogenesis / urinary tract infection / chronic / anaphylaxis / angioedema / exfoliative skin conditions / diabetes / hyperlipidemia / true hypoglycemia / serious hypersensitivity / fatal pancreatitis / diabetes mellitus / diabetic ketoacidosis / urticaria / angioedema / pancreatitis / hypersensitivity / Precautions Pancreatitis / type 2 diabetes mellitus / bronchial hyperreactivity / cough / acute pancreatitis / constipation / Cause Hypoglycemia / Hypoglycemia / chronic renal impairment / Rash / upper respiratory tract infection / / MedicalTreatment peritoneal dialysis / hemodialysis / insulin therapy / / Organization Excretion Following administration / Poison Control Center / DOSAGE AND ADMINISTRATION / FDA / / / Position investigator / forward / / Product pioglitazone / talc / levonorgestrel / TRADJENTA tablets / Simvastatin / digoxin / glucagon / glimepiride / polyethylene glycol / Glyburide / mannitol / rifampin / Combination Therapy TRADJENTA tablets / CYP3A4 / / Technology alpha / Pharmacokinetics / Pharmacodynamics / dialysis / / URL www.fda.gov / /
SocialTag |
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRADJENTA safely and effectively. See full prescribing information for TRADJENTA. Tradjenta® (linagliptin) tablets